How does ChatGPT work? And its creator? Are you ready to cooperate with the vaccine?

Published Date: 16 Feb 2023

Chatbots have shields to control misinformation, but it will continue to be a game.

Read Full News

Latest News

Universal Bulk Billing Requires More Than Good Intentions

General practitioners support affordable access to care, but universal bulk billing can only succeed if it is backed by sustainable funding.

Rethinking Routine Screening of Asymptomatic Patients

A normal result feels like good medicine. For patients and physicians alike, it provides peace of mind. But when the evidence doesn't support the test, that reassurance comes at a price.

Childhood Abuse Tied to Higher Migraine Risk in Men

Childhood abuse is linked to an increased risk for past-year and lifetime migraine in men but not in women, with depression partially mediating the link, a study suggests.

Medical Trainees May Help Up Advance Care Planning

A brief trainee-led educational session may boost completion of Durable Power of Attorney for Healthcare forms and billing for advance care planning-related codes in older adults in primary care.

One Conversation Makes Testing Less Stressful for Patients

While ordering medical tests is routine, a lack of communication often leaves anxious patients decoding portal results alone. These communication strategies can help.

AI vs GIs: Who Detects Early Esophageal Cancer Better?

Endoscopy-based deep learning algorithms demonstrate higher sensitivity and specificity than endoscopists overall in detecting early esophageal squamous cell carcinoma.

Todays Updates

AI-Driven Biomarker Predicts Prostate Cancer Outcomes

The tool, based on histology only, may help identify patients most likely to benefit from triplet therapy.

Community Oncology Well Suited for Advanced Cancer Patients

Experts tout common characteristics of local physician practices that are beneficial to those with advanced disease.

Todays Updates

AI-Driven Biomarker Predicts Prostate Cancer Outcomes

The tool, based on histology only, may help identify patients most likely to benefit from triplet therapy.

Community Oncology Well Suited for Advanced Cancer Patients

Experts tout common characteristics of local physician practices that are beneficial to those with advanced disease.

Latest News

General practitioners support affordable access to care, but universal bulk billing can only succeed if it is backed by sustainable funding.

A normal result feels like good medicine. For patients and physicians alike, it provides peace of mind. But when the evidence doesn't support the test, that reassurance comes at a price.

Childhood abuse is linked to an increased risk for past-year and lifetime migraine in men but not in women, with depression partially mediating the link, a study suggests.

A brief trainee-led educational session may boost completion of Durable Power of Attorney for Healthcare forms and billing for advance care planning-related codes in older adults in primary care.

While ordering medical tests is routine, a lack of communication often leaves anxious patients decoding portal results alone. These communication strategies can help.

Endoscopy-based deep learning algorithms demonstrate higher sensitivity and specificity than endoscopists overall in detecting early esophageal squamous cell carcinoma.

News All Time

Lead and Mercury Levels Drop Markedly in UK Pregnancy

Blood lead and mercury levels fall markedly among pregnant women in the UK since the early 1990s, and methylmercury accounts for most mercury detected in the blood.

Social Needs Screening Not Associated With Use of Services

Social needs intervention in US pediatric practices is associated with higher rates of self-reported social needs discussions and referrals but not higher resource enrollment.

Professional Corner: Resident Well-Being, Maternity, & More

New study finds nearly 10% of internal medicine residents report a disability; the American Medical Association updates maternity care billing codes; and Texas joins autism trial network.

Venetoclax-Obinutuzumab Boosts MRD Clearance in CLL

A phase 3 trial compares first-line fixed-duration venetoclax-obinutuzumab to fludarabine, cyclophosphamide, and rituximab/bendamustine-rituximab in patients with CLL.

Low-Dose Atropine for Childhood Myopia: Worth Using?

A UK trial finds that low-dose atropine modestly slows childhood myopia progression and axial eye growth over 2 years without increasing adverse events.

Functional Cure for Hepatitis B Is Now ‘Achievable’

Bepirovirsen reduced posttreatment markers of hepatitis B infection at 72 weeks, with 20% of recipients achieving functional cure vs none given placebo.

Wrist and Knuckle Joints Show Slower Therapy Response in RA

Swelling in the wrist and certain metacarpophalangeal joints may resolve slower than that in other joints after starting advanced treatments in patients with rheumatoid arthritis, a study finds.

Deep Brain Stimulation: Can Remote Follow-Up Expand Access?

Remote programming allows clinicians to adjust deep brain stimulation from a distance, improving access to specialist follow-up while reducing routine clinic visits.

Rheumatologist Shortage to Hit Nonmetropolitan Areas Hardest

Workforce projections show an uneven distribution of rheumatologists in the US, with notable shortages in nonmetropolitan areas and certain states and districts.

Epcoritamab Shows Promise in Frail Older Adults With LBCL

A phase 2 trial assesses fixed-duration epcoritamab monotherapy as first-line therapy for frail older adults with newly diagnosed anthracycline-ineligible large B-cell lymphoma.

US Nuclear Power Regulator Proposes Changing Rule Protecting People From Radiation

The U.S. nuclear power regulator on Wednesday proposed changes to a rule protecting people from radiation, the latest proposal pushed by the Trump administration to change...

A Man With a Recurrent Scalp Tumor

A recurrent scalp mass initially diagnosed as a pilomatrixoma is ultimately found to be a rare adnexal malignancy, underscoring the need for histologic precision.

AI-Generated Presentations: Can Better Prompts Save Time?

Structured prompts help physicians prepare conference presentations faster, but expert review remains essential to verify evidence, references, and scientific accuracy.

Higher Daytime Light Exposure Linked to Lower Dementia Risk

Exposure to relatively bright daytime light is linked to lower dementia risk and may provide a novel, measurable method to identify individuals at high risk for dementia.

AI May Help Predict Liver Cancer Risk in Young Adults

A machine learning algorithm predicts early-onset liver cancer in young adults better than traditional models.

Prior Stillbirth May Up Risk for Subsequent Stillbirth

Individuals with a prior stillbirth have more than double the risk for stillbirth in their next pregnancy, with the risk increasing sixfold when the initial loss is due to placental insufficiency.

Recommended News For You

Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.

Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC

High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer

Encounters matter in cancer care: Health care professionals can play a key role in restoring patients' sense of control

High weight and obesity are associated with poor outcomes in leukemia treatment.

Committee Recommends Canada Not Permit Euthanasia Solely for Mental Illness

Report reveals lung cancer is the leading cause of cancer deaths in Florida

Recommended Articles For You

The Unfolding Revolution of Precision Medicine, Immunotherapy, and Digital Transformation in Medical Oncology 2025 

Targeted Therapy: Latest Advances, Learning Tools, Trials & Treatment Options Explained 

PARP Inhibitors in Testicular Cancer: Tackling Cisplatin Resistance with Precision 

Engineered Red Blood Cell Therapeutics: Emerging Applications 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

EVP Beats Cisplatin for Resectable MIBC

2.

After three years, responses to mounetuzumab in follicular lymphoma are still stable.

3.

In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.

4.

Chronic stress and obesity work together to accelerate pancreatic cancer development and growth, study finds

5.

A three-quarters reduction in the risk of prostate cancer is associated with an annual increase in cardiorespiratory fitness of more than three percent.

1.

Exploring the Potential of Xospata: A New Frontier in Cancer Treatment

2.

Prognostic Role of PLAU in Pan-Cancer and Neutrophil Infiltration in Bladder Cancer

3.

CAR T-Cell Therapy: Revolutionizing Hematologic Malignancies

4.

Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers

5.

Managing High Potassium Levels: A Comprehensive Guide to Veltassa 

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II

2.

Navigating the Complexities of Ph Negative ALL - Part X

3.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

4.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot